Update on continuous ambulatory peritoneal dialysis

Ramesh Khanna, George Wu, S. Vas, George Digenis, Dimitrios G. Oreopoulos

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

By now many patients have been successfully maintained on CAPD for five years or more, thus demonstrating that CAPD is a viable long-term treatment for end-stage renal disease. Peritonitis-the main concern of the earlier years-is now a less frightening complication. We know better how to treat peritonitis and its incidence has decreased from one episode every 8 months initially to one episode every 18 months now. In addition, several innovations, which have been or soon will be introduced, promise to decrease the frequency of peritonitis to an even lower rate. The problem of peritonitis is now being replaced by the chronic complications of CAPD, predominantly malnutrition and decrease in peritoneal ultrafiltration. CAPD has become an important adjunct in the treatment of children with ESRD, especially the very young. Even though not normal, their growth on CAPD is better than that of children on hemodialysis and as good as that after a successful transplant. CAPD has become a promising treatment for the diabetic with ESRD. This experience has stimulated interest and research in the role of intraperitoneal administration of insulin for blood glucose control. With the present worldwide experience of CAPD, this treatment has ceased to be experimental. A percentage of patients requiring dialysis will be better off on CAPD than on hemodialysis. Even though this percentage will vary among various countries, the nephrologist who wants to provide the best treatment for each patient must be well experienced in and have all treatments at his disposal including CAPD.

Original languageEnglish
Pages (from-to)381-395
Number of pages15
JournalLa Ricerca in Clinica e in Laboratorio
Volume13
Issue number4
DOIs
Publication statusPublished - Oct 1983

Fingerprint

Transplants
Dialysis
Continuous Ambulatory Peritoneal Dialysis
Ultrafiltration
Blood Glucose
Innovation
Insulin
Peritonitis
Chronic Kidney Failure
Renal Dialysis
Therapeutics
Malnutrition
Incidence

Keywords

  • Continuous ambulatory peritoneal dialysis
  • Diabetes mellitus
  • End-stage renal disease
  • Infections
  • Malnutrition
  • Peritoneal ultrafiltration
  • Peritonitis

ASJC Scopus subject areas

  • Clinical Biochemistry

Cite this

Update on continuous ambulatory peritoneal dialysis. / Khanna, Ramesh; Wu, George; Vas, S.; Digenis, George; Oreopoulos, Dimitrios G.

In: La Ricerca in Clinica e in Laboratorio, Vol. 13, No. 4, 10.1983, p. 381-395.

Research output: Contribution to journalArticle

Khanna, Ramesh ; Wu, George ; Vas, S. ; Digenis, George ; Oreopoulos, Dimitrios G. / Update on continuous ambulatory peritoneal dialysis. In: La Ricerca in Clinica e in Laboratorio. 1983 ; Vol. 13, No. 4. pp. 381-395.
@article{26fffe4b82924feda3340237f8fb8f8f,
title = "Update on continuous ambulatory peritoneal dialysis",
abstract = "By now many patients have been successfully maintained on CAPD for five years or more, thus demonstrating that CAPD is a viable long-term treatment for end-stage renal disease. Peritonitis-the main concern of the earlier years-is now a less frightening complication. We know better how to treat peritonitis and its incidence has decreased from one episode every 8 months initially to one episode every 18 months now. In addition, several innovations, which have been or soon will be introduced, promise to decrease the frequency of peritonitis to an even lower rate. The problem of peritonitis is now being replaced by the chronic complications of CAPD, predominantly malnutrition and decrease in peritoneal ultrafiltration. CAPD has become an important adjunct in the treatment of children with ESRD, especially the very young. Even though not normal, their growth on CAPD is better than that of children on hemodialysis and as good as that after a successful transplant. CAPD has become a promising treatment for the diabetic with ESRD. This experience has stimulated interest and research in the role of intraperitoneal administration of insulin for blood glucose control. With the present worldwide experience of CAPD, this treatment has ceased to be experimental. A percentage of patients requiring dialysis will be better off on CAPD than on hemodialysis. Even though this percentage will vary among various countries, the nephrologist who wants to provide the best treatment for each patient must be well experienced in and have all treatments at his disposal including CAPD.",
keywords = "Continuous ambulatory peritoneal dialysis, Diabetes mellitus, End-stage renal disease, Infections, Malnutrition, Peritoneal ultrafiltration, Peritonitis",
author = "Ramesh Khanna and George Wu and S. Vas and George Digenis and Oreopoulos, {Dimitrios G.}",
year = "1983",
month = "10",
doi = "10.1007/BF02906919",
language = "English",
volume = "13",
pages = "381--395",
journal = "Ricerca in Clinica e in Laboratorio",
issn = "0390-5748",
publisher = "Il Ponte",
number = "4",

}

TY - JOUR

T1 - Update on continuous ambulatory peritoneal dialysis

AU - Khanna, Ramesh

AU - Wu, George

AU - Vas, S.

AU - Digenis, George

AU - Oreopoulos, Dimitrios G.

PY - 1983/10

Y1 - 1983/10

N2 - By now many patients have been successfully maintained on CAPD for five years or more, thus demonstrating that CAPD is a viable long-term treatment for end-stage renal disease. Peritonitis-the main concern of the earlier years-is now a less frightening complication. We know better how to treat peritonitis and its incidence has decreased from one episode every 8 months initially to one episode every 18 months now. In addition, several innovations, which have been or soon will be introduced, promise to decrease the frequency of peritonitis to an even lower rate. The problem of peritonitis is now being replaced by the chronic complications of CAPD, predominantly malnutrition and decrease in peritoneal ultrafiltration. CAPD has become an important adjunct in the treatment of children with ESRD, especially the very young. Even though not normal, their growth on CAPD is better than that of children on hemodialysis and as good as that after a successful transplant. CAPD has become a promising treatment for the diabetic with ESRD. This experience has stimulated interest and research in the role of intraperitoneal administration of insulin for blood glucose control. With the present worldwide experience of CAPD, this treatment has ceased to be experimental. A percentage of patients requiring dialysis will be better off on CAPD than on hemodialysis. Even though this percentage will vary among various countries, the nephrologist who wants to provide the best treatment for each patient must be well experienced in and have all treatments at his disposal including CAPD.

AB - By now many patients have been successfully maintained on CAPD for five years or more, thus demonstrating that CAPD is a viable long-term treatment for end-stage renal disease. Peritonitis-the main concern of the earlier years-is now a less frightening complication. We know better how to treat peritonitis and its incidence has decreased from one episode every 8 months initially to one episode every 18 months now. In addition, several innovations, which have been or soon will be introduced, promise to decrease the frequency of peritonitis to an even lower rate. The problem of peritonitis is now being replaced by the chronic complications of CAPD, predominantly malnutrition and decrease in peritoneal ultrafiltration. CAPD has become an important adjunct in the treatment of children with ESRD, especially the very young. Even though not normal, their growth on CAPD is better than that of children on hemodialysis and as good as that after a successful transplant. CAPD has become a promising treatment for the diabetic with ESRD. This experience has stimulated interest and research in the role of intraperitoneal administration of insulin for blood glucose control. With the present worldwide experience of CAPD, this treatment has ceased to be experimental. A percentage of patients requiring dialysis will be better off on CAPD than on hemodialysis. Even though this percentage will vary among various countries, the nephrologist who wants to provide the best treatment for each patient must be well experienced in and have all treatments at his disposal including CAPD.

KW - Continuous ambulatory peritoneal dialysis

KW - Diabetes mellitus

KW - End-stage renal disease

KW - Infections

KW - Malnutrition

KW - Peritoneal ultrafiltration

KW - Peritonitis

UR - http://www.scopus.com/inward/record.url?scp=0020839736&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020839736&partnerID=8YFLogxK

U2 - 10.1007/BF02906919

DO - 10.1007/BF02906919

M3 - Article

VL - 13

SP - 381

EP - 395

JO - Ricerca in Clinica e in Laboratorio

JF - Ricerca in Clinica e in Laboratorio

SN - 0390-5748

IS - 4

ER -